Navigation Links
IDEXX Laboratories Announces Fourth Quarter and Full Year Results
Date:1/30/2009

Net cash provided by operating activities $143,343 $135,124 Investing: Cash Flows from Investing Activities: Decrease in investments, net - 35,000 Purchase of property and equipment (89,237) (65,138) Acquisition of businesses and intangible assets (8,649) (89,884) Proceeds from sale of assets 7,025 - Acquisition of equipment leased to customers (734) (1,106) Net cash used by investing activities $(91,595) $(121,128) Financing: Cash Flows from Financing Activities: Borrowings under notes payable, net 78,955 69,992 Purchase of treasury stock (132,342) (118,387) Proceeds from the exercise of stock options 16,360 20,941 Tax benefit from exercise of stock options 6,237 9,267 Net cash used by financing activities $(30,790) $(18,187) Net effect of exchange rate changes (2,450) 2,885 Net decrease in cash and cash equivalents 18,508 (1,306) Cash and cash equivalents, beginning of period 60,360 61,666 Cash and cash equivalents, end of period $78,868 $60,360

    IDEXX Laboratories
'/>"/>
SOURCE IDEXX Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
2. IDEXX Laboratories Names William Brown Corporate Vice President
3. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
4. IDEXX Laboratories to Release 2008 First Quarter Financial Results
5. IDEXX Laboratories Announces Increase in Share Repurchase Program
6. IDEXX Laboratories Announces Fourth Quarter Results
7. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
8. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009
10. Bedford Laboratories(TM) to Begin Shipping Irinotecan HCl Injection
11. Metametrix Announces Acquisition of Accu-Chem Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... 28, 2015 How would you ... , There are all kinds of different leaders, ... awareness of the advantages and applications of different ... launching a new product this spring called The ... the connection between personality type, leadership, and success. ...
(Date:2/28/2015)... 28, 2015 The noted Toronto plastic ... Surgery was recently featured in the January/February 2015 issue ... Dr. David Ellis was featured in an article entitled ... cosmetic enhancements that Kim Cattrall has possibly undergone to ... forehead is smooth without horizontal lines or frown line ...
(Date:2/28/2015)... February 28, 2015 “ Powermod ” was ... which takes a look at the latest and coolest technology ... reporter for NewsWatch and a technology expert, conducted the review ... of charging solutions. , Getting stuck with a low battery ... a problem that people face on a daily basis. Even ...
(Date:2/28/2015)... The World Scout League Commission (WSLC), ... potential EMTs and firefighters, recently announced its decision to ... to raise charitable donations for age-related research. The five-kilometer ... be held on March 29, 2015; registration will start ... 3:30 p.m. , To participate in the race, ...
(Date:2/27/2015)... Sacramento, Calif. (PRWEB) February 27, 2015 ... of liver-disease death, between four and 12 years earlier ... study from UC Davis Health System. , While previous ... ALD than other populations, the new study -- published ... -- is believed to be the first to pinpoint ...
Breaking Medicine News(10 mins):Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2
... University of North Carolina at Chapel Hill have launched a ... help prevent depression and cardiovascular illness in women between the ... may raise eyebrows in some quarters, given that a Women,s ... findings that estrogen therapy resulted in an increased risk of ...
... geneticist Pier Paolo Pandolfi, MD, PhD, is the recipient ... Research) International Award for Cancer Research. This is the ... BIDMC investigator has received this prestigious honor, which was ... renown who has made a major scientific discovery in ...
... the Peninsula College of Medicine and Dentistry are part of ... implement a 4.7m Policy Research Unit dedicated to achieving early ... years by the Department of Health and will be led ... the project include Barts and the London School of Medicine ...
... , WEDNESDAY, Jan. 12 (HealthDay News) -- Even though ... understand many spoken words and use the same brain structures ... The findings challenge the widely held belief that infants ... words, and that this ability begins primitively and evolves into ...
... HealthDay Reporter , TUESDAY, Jan. 11 (HealthDay News) -- Over ... blood pressure drug candesartan stood a higher chance of survival ... fact, 61 percent of those taking candesartan (Atacand) survived, compared ... may be due to differences in the way the drugs ...
... Use of an artery from the arm rather than a ... coronary artery bypass graft (CABG) patients, according to a new ... means that the graft is open and unobstructed -- in ... arm,s radial artery was used in 366 patients and the ...
Cached Medicine News:Health News:UNC researchers investigate estrogen to prevent depression and cardiovascular disease 2Health News:Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research 2Health News:Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research 3Health News:Funding to improve cancer survival rates 2Health News:Infants Process Words Much Like Adults, Study Finds 2Health News:Not All Heart Failure Drugs Boost Survival Equally 2
(Date:2/26/2015)... , February 27, 2015 ... H2 2014 market research report to its store. ... Corneal Ulcers, therapeutic pipeline. The report ... on the therapeutic development for Corneal Ulcers. Corneal ... that includes bacterial infections, viral infections & fungal ...
(Date:2/26/2015)... , Feb. 26, 2015  AbbVie (NYSE: ... abstracts of studies in its neuroscience and oncology ... the 67 th American Academy of Neurology ... , from April 18-25. The accepted abstracts feature ... in addition to investigational treatments in AbbVie,s pipeline. ...
(Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015  IRIDEX ... will release its fourth quarter and full year 2014 financial ... 2015.   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, March 5, ... other business developments. Interested parties may access the ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
... Calif., Jan. 4, 2011 PneumRx, Inc. ( www.pneumrx.com ... and improvements to the treatment of lung disease, today ... capital commitments.  The oversubscribed round was led by Forbion ... venture capital firms from Europe, and also included a ...
... 2011 OrbusNeich today announced that the United States Patent ... protection of the company,s Genous endothelial progenitor cell (EPC) capture ... covers a coating on an implantable medical device that has ... matrix are antibodies or antibody fragments that allow for capture ...
Cached Medicine Technology:PneumRx, Inc. Raises $33 Million in Capital 2PneumRx, Inc. Raises $33 Million in Capital 3OrbusNeich Granted Expanded U.S. Patent of Genous™ Endothelial Progenitor Cell Capture Technology 2
... of Vision and Contrast Sensitivity. The ... and glare luminance levels for accurate ... with/without glare and background luminance Comply ... standards. All Light Levels Microprocessor Controlled ...
... profitability by reducing ... simple test,sequences that ... by ancillary office ... 5 minutes. New ...
Holladay Contract Acuity Test provides a more sensitive evaluation for testing visual functions than standard acuity charts....
Vectograms are the standard for vision training. They are available in fixed or variable,styles to accommodate unlimited base-in and base-out training. Each vectogram,includes one pair,of standard 3-...
Medicine Products: